Evidence map›Paper›PMID 39861062›Full record

ArticlePathogens (Basel, Switzerland)2025

Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study.

Oludare 'Sunbo Adewuyi, Muhammad Shakir Balogun, Hirono Otomaru, Alash'le Abimiku, Anthony Agbakizu Ahumibe, Elsie Ilori, Que Anh Luong, Nwando Mba, James Christopher Avong, John Olaide and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Oludare 'Sunbo AdewuyiGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0002-8569-9521
Muhammad Shakir BalogunNigeria Field Epidemiology and Laboratory Training Programme, Abuja 900231, Nigeria.ORCID 0000-0002-4846-9698
Hirono OtomaruDepartment of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Alash'le AbimikuInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0003-2213-0204
Anthony Agbakizu AhumibeGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.
Elsie IloriNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Que Anh LuongDepartment of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0009-0006-9621-9286
Nwando MbaNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
James Christopher AvongNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
John OlaideDepartment of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0002-1761-0919
Oyeladun OkunromadeNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.ORCID 0000-0002-8242-8590
Adama AhmadNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Afolabi AkinpeluNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Chinwe Lucia OchuNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.ORCID 0000-0002-0630-7332
Babatunde OlajumokeNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Haruka AbeVietnam Research Station, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0003-0141-5059
Chikwe IhekweazuNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Adetifa IfedayoNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Michiko ToizumiDepartment of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0002-8401-9344
Hiroyuki MoriuchiGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0001-7448-8115
Katsunori YanagiharaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.
Jide IdrisNigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
Lay-Myint YoshidaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0002-7567-3248

Funding

Japan Society for the Promotion of Science, Japan 22KK0147
6 · The paper itself

Abstract

Information on circulating HBV (sub-)genotype, variants, and hepatitis D virus (HDV) coinfection, which vary by geographical area, is crucial for the efficient control and management of HBV. We investigated the genomic characteristics of HBV (with a prevalence of 8.1%) and the prevalence of HDV in Nigeria. We utilised 777 HBV-positive samples and epidemiological data from the two-stage sampled population-based, nationally representative Nigeria HIV/AIDS Indicator and Impact Survey conducted in 2018. We assessed 732 HBV DNA-extracted samples with detectable viral loads (VLs) for (sub-)genotypes and variants by whole-genome pre-amplification, nested PCR of the

Indexed as

Drug Resistance, ViralHepatitis BHepatitis B virusHepatitis DHepatitis Delta VirusAdolescentAdultAgedAntiviral AgentsChildCoinfectionDNA, ViralFemaleGenotypeHumansMaleAntiviral AgentsDNA, Viraldrug-resistant associated variantsgenotypesHBVHDVNigeriaviral load

Identifiers

PMID39861062
PMCPMC11768191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.